ArticleJournal of microbiology and biotechnology2026
A Water-Soluble Curcumin Glycoside Exhibits Superior Anti-Colitic Efficacy over Native Curcumin in DSS-Induced Colitis through Anti-Inflammatory Activity and Gut Microbiota Modulation.
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin is a hydrophobic polyphenol with diverse biological activities; however, its practical application is limited by poor water solubility and low oral bioavailability. In this study, we investigated whether TSP, a previously developed water-soluble curcumin-stevioside glycoside, exerts superior anti-colitic efficacy compared with native curcumin. In LPS-stimulated macrophages, TSP more effectively suppressed IL-6 and TNF-α production than curcumin under aqueous conditions, indicating greater anti-inflammatory activity in a physiologically relevant environment. In a dextran sulfate sodium (DSS)-induced mouse colitis model, oral administration of TSP ameliorated disease severity more effectively than native curcumin administered at an equivalent curcumin dose, as evidenced by reduced body weight loss, preservation of colon length, improved histopathological features, and restoration of intestinal barrier integrity. TSP also was associated with altered gut microbial diversity and composition relative to the DSS group, including enrichment of short-chain fatty acid (SCFA)-associated taxa, particularly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.